- Home
- HBB vs STRO Comparison
HBB vs STRO Comparison
Compare HBB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HBB | STRO |
|---|---|---|
| Founded | 1904 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.8M | 94.9M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HBB | STRO |
|---|---|---|
| Price | $16.40 | $9.95 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.67 |
| AVG Volume (30 Days) | 21.5K | ★ 110.9K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | ★ 24.53 | N/A |
| EPS | ★ 2.34 | N/A |
| Revenue | ★ $607,430,000.00 | $105,646,000.00 |
| Revenue This Year | N/A | $62.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.72 | $5.23 |
| 52 Week High | $21.20 | $24.80 |
Technical Indicators
Market Signals| Indicator | HBB | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 88.14 |
| Support Level | $15.24 | $9.53 |
| Resistance Level | $17.06 | $10.10 |
| Average True Range (ATR) | 0.77 | 0.70 |
| MACD | 0.09 | 0.52 |
| Stochastic Oscillator | 95.05 | 97.87 |
Price Performance
Historical ComparisonAbout HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.